AbbVie, Sanofi-backed Principia offers an $86M IPO after burning through $148M for pipeline work

It’s time for some new biotech IPOs to test the waters on Nasdaq. With some substantial backing from Sanofi and AbbVie, Principia BioPharma out of South San Francisco is getting ready to roll the dice on an IPO on Nasdaq.